Cardiovascular Outcomes Following Therapeutic Sclerostin Inhibition Compared With Alternative Anabolic Therapies: A Real‐World Propensity Score–Matched Analysis

Journal of Osteoporosis · Published 2026-01-01 · DOI 10.1155/joos/2813928

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1155/joos/2813928

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Quantitative MR Analysis of Changes in the Radius Bone Marrow in Osteoporosis · Journal of Osteoporosis · 2023 · Same journal
• Association of Postoperative Neutrophil Lymphocyte Ratio (NLR) and Monocyte Lymphocyte Ratio (MLR) with the Presence of Osteoporosis in Japanese Patients after Hip Fracture Surgery: A Retrospective Cohort Study · Journal of Osteoporosis · 2021 · Same journal
• Correlation between Urine N-Terminal Telopeptide and Fourier Transform Infrared Spectroscopy Parameters: A Preliminary Study · Journal of Osteoporosis · 2020 · Same journal
• Vertebral Augmentation for Painful Type 4 Osteoporotic Compression Fractures: A Comparative Study · Journal of Osteoporosis · 2023 · Same journal
• “Omics” Signatures in Peripheral Monocytes from Women with Low BMD Condition · Journal of Osteoporosis · 2018 · Same journal
• A Phase IV Study of the Safety and Efficacy of CinnoPar® in Iranian Patients with Osteoporosis · Journal of Osteoporosis · 2021 · Same journal
• Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis · Journal of Osteoporosis · 2016 · Same journal
• Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges · Journal of Osteoporosis · 2016 · Same journal
• The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model · Journal of Osteoporosis · 2023 · Same journal
• Nutritional Aspects of Bone Health and Fracture Healing · Journal of Osteoporosis · 2017 · Same journal